Chronic Constipation
- PMID: 31054770
- PMCID: PMC6829047
- DOI: 10.1016/j.mayocp.2019.01.031
Chronic Constipation
Abstract
Constipation is a common symptom that may be primary (idiopathic or functional) or associated with a number of disorders or medications. Although most constipation is self-managed by patients, 22% seek health care, mostly to primary care physicians (>50%) and gastroenterologists (14%), resulting in large expenditures for diagnostic testing and treatments. There is strong evidence that stimulant and osmotic laxatives, intestinal secretagogues, and peripherally restricted μ-opiate antagonists are effective and safe; the lattermost drugs are a major advance for managing opioid-induced constipation. Constipation that is refractory to available laxatives should be evaluated for defecatory disorders and slow-transit constipation using studies of anorectal function and colonic transit. Defecatory disorders are often responsive to biofeedback therapies, whereas slow-transit constipation may require surgical intervention in selected patients. Both efficacy and cost should guide the choice of treatment for functional constipation and opiate-induced constipation. Currently, no studies have compared inexpensive laxatives with newer drugs that work by other mechanisms.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interest: Dr. Bharucha reports personal fees from Allergan, personal fees from Forum Pharmaceuticals, personal fees from Macmillan Medical Communications, personal fees from Salix Pharma, outside the submitted work; In addition, Dr. Bharucha has a patent Portable anorectal manometry device with royalties paid to Medspira, and a patent Anorectal manometry probe fixation device licensed to Medtronic. Dr. Wald reports personal fees from Ironwood Pharma, personal fees from Takeda/Sucampo, personal fees from Theravance, personal fees from Shire, personal fees from EnteraHealth, outside the submitted work.
Figures



Similar articles
-
Constipation: Advances in Diagnosis and Treatment.JAMA. 2016 Jan 12;315(2):185-91. doi: 10.1001/jama.2015.16994. JAMA. 2016. PMID: 26757467 Review.
-
Mechanisms, Evaluation, and Management of Chronic Constipation.Gastroenterology. 2020 Apr;158(5):1232-1249.e3. doi: 10.1053/j.gastro.2019.12.034. Epub 2020 Jan 13. Gastroenterology. 2020. PMID: 31945360 Free PMC article. Review.
-
Chronic Constipation in Adults.Am Fam Physician. 2022 Sep;106(3):299-306. Am Fam Physician. 2022. PMID: 36126011
-
Pathophysiology, diagnosis, and management of opioid-induced constipation.Lancet Gastroenterol Hepatol. 2018 Mar;3(3):203-212. doi: 10.1016/S2468-1253(18)30008-6. Lancet Gastroenterol Hepatol. 2018. PMID: 29870734 Review.
-
Constipation: pathophysiology and management.Curr Opin Gastroenterol. 2015 Jan;31(1):45-9. doi: 10.1097/MOG.0000000000000137. Curr Opin Gastroenterol. 2015. PMID: 25394234 Review.
Cited by
-
Association of sleep duration with chronic constipation among adult men and women: Findings from the National Health and Nutrition Examination Survey (2005-2010).Front Neurol. 2022 Aug 10;13:903273. doi: 10.3389/fneur.2022.903273. eCollection 2022. Front Neurol. 2022. PMID: 36034289 Free PMC article.
-
Integrated serum pharmacochemistry, 16S rDNA sequencing, and metabolomics to reveal the material basis and mechanism of Shouhui Tongbian capsule against diphenoxylate-induced slow transit constipation in rats.Chin Med. 2024 Oct 11;19(1):142. doi: 10.1186/s13020-024-01015-8. Chin Med. 2024. PMID: 39394615 Free PMC article.
-
A Shigella species variant is causally linked to intractable functional constipation.J Clin Invest. 2022 Jul 15;132(14):e150097. doi: 10.1172/JCI150097. J Clin Invest. 2022. PMID: 35617029 Free PMC article.
-
Runchangningshen paste activates NLRP6 inflammasome-mediated autophagy to stimulate colonic mucin-2 secretion and modulates mucosal microbiota in functional constipation.World J Gastroenterol. 2025 Mar 7;31(9):102256. doi: 10.3748/wjg.v31.i9.102256. World J Gastroenterol. 2025. PMID: 40061589 Free PMC article.
-
Shouhui Tongbian Capsule ameliorates 5-fluorouracil induced constipation in mice by modulating gut microbiota and activating PI3K/AKT/AQP3 signaling pathway.Front Microbiol. 2025 Jul 10;16:1596881. doi: 10.3389/fmicb.2025.1596881. eCollection 2025. Front Microbiol. 2025. PMID: 40708926 Free PMC article.
References
-
- Sandler RS, Drossman DA. Bowel habits in young adults not seeking health care. Dig. Dis. Sci 1987;32(8):841–845. - PubMed
-
- Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology 2016;18:18. - PubMed
-
- Bouchoucha M, Devroede G, Mary F, Bon C, Bejou B, Benamouzig R. Painful or mild-pain constipation? A clinically useful alternative to classification as irritable bowel syndrome with constipation versus functional constipation. Dig. Dis. Sci 2018. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials